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INTRODUCTION
Bacterial infections can affect pregnant women prior to implantation 
of the fertilized ovum, during pregnancy and delivery. These infections can 
also affect the fetus and newborn. Many women with these infections are 
asymptomatic necessitating, both a high degree of clinical suspicion and 
adequate screening tests.
Group B streptococcus (GBS) in recent times, has emerged as a 
leading cause of invasive bacterial infections in newborn globally. The 
recognition, that maternal colonization with the organism is a key factor, in 
the occurrence of group B streptococci associated neonatal morbidity and 
mortality has thus made the pathogen the primary focus of discussion about 
infection and pregnancy.
While advances in prevention strategies have led to the decline in the 
incidence of neonatal disease in the recent times, Group B streptococcus still 
remains a major pathogen for neonate, pregnant women and immuno 
compromised non pregnant adults.
Epidemiology
Before the wide spread use of intrapartum antibiotics, group B 
streptococcus emerged as the leading cause of invasive bacterial infections 
in the newborns ranging from 20 to 50%1 in different parts of the globe. 
However, in the present era of antibiotics,  the incidence of perinatal group 
B streptococcal disease ranges from 12 to 26% depending upon the 
prevailing health facilities and socio economic conditions in that part of the 
world.
Epidemiological studies in India have shown maternal colonization 
rates ranging from12-18% 2. Reported perinatal transmission rates in the 
newborn ranges from 53 to 56%. However the incidence of invasive 
perinatal disease is only 0.17 per thousand live births1. This number 
represents only those cases occurring in a tertiary care hospital. In India 
where there is a limited system of national registry, the true incidence of the 
disease remains largely unknown. Since all the preterm and still births are 
not adequately investigated, the total burden of this particular infection 
remains largely under estimated.
Etiology:
Streptococcus agalactiae or Group B streptococcus is a facultative 
beta hemolytic fastidious, gram-positive capsulated coccus.
When cultured on sheep blood agar they form glistening gray white 
colonies, with a narrow zone of beta hemolysis.
The organism contains a Lancefield grouping antigen, a type specific 
cell surface polysaccharide and protein antigens. The group B antigen is 
composed of rhamnose- glucosamine polymer attached to peptidoglycan 
layer. The type specificity is provided, by both capsular poly saccharide and 
protein antigens. Group B streptococci are invariably encapsulated and 
belong to one of the nine recognized capsular serotypes. 
The nine capsular types are composed of glucose, galactose, N-acetyl 
glucosamine, N- acetyl muraminic acid. Serotype specificity is recognized, 
by differing arrangements of one of the nine capsular serotypes. The 
polysaccharide capsule antigen is designated by Ia and b, II, III, IV, V, VI, 
VII, and VIII. The protein antigen is designated by the single letter c.
Group B streptococcus produces a variety of potential virulence 
determinants. These include 
1. Beta hemolysin
2. C5a peptidase
3. Lipotechoic acid
4. Cell surface protein
5. Hyaluronic acid lyase
6. Cell surface penicillin binding protein.  
Group B streptococcus colonization and transmission:
The gastro intestinal tract serves as a natural reservoir for group B 
streptococcus and is the chief source of vaginal colonization. Vaginal 
colonization is unusual in childhood, but becomes more common in the 
adolescence. Approximately 10-30 percent of pregnant women are colonized 
with the organism in vagina and rectum1. Intra partum transmission occurs 
via ascending spread from this colonization.
Clinical spectrum
Maternal Infections:
Group B streptococcus can cause significant morbidity in pregnant 
women. The manifestations include
1. Chorio amnionitis
2. Endometritis
3. Cystitis
4. Pyelonephritis
5. Febrile bacteremia2
6. Post partum endometritis, following caesarean delivery3
7. Prolonged labour,
8. Premature rupture of membranes(PROM)4
9. Preterm delivery4
Less commonly it is associated with
1. Post partum fever
2. Wound infections
3. Pelvic abcess
4. Septic pelvic thrombophlebitis 5
5. Osteomyelitis
6. Neonatal Infections:
In the newborn, group B streptococcal infection can manifest as two 
different diseases depending on the time from delivery at which symptoms 
manifest6.
Neonatal manifestations of group B streptococcal disease 1
Early onset disease Late onset disease
Onset First week of life 
(usually within the first 
24 hrs)
After one week to 3 
months of age
Clinical presentation Respiratory distress 
Pneumonia, Sepsis
Sepsis, Meningitis 
Osteoarthritis
Incidence of 
Prematurity
Increased No change
Maternal obstetrical 
complications
Frequent (70%) Uncommon
Transmission Vertical: acquired in 
utero or intrapartum
Usually horizontal 
transmission; can also 
be intrapartum
Predominant serotypes Ia, III, V III, Ia, V
Mortality (%) 10 -15 2 – 6
 Screening and Detection of Group B streptococcus colonization 
In 1996 the Centre for Disease Control and prevention (CDC) 
published consensus guidelines recommending two methods of perinatal 
group B streptococcal disease prevention. 
1. The screening based approach which recommends obtaining vaginal and 
rectal  cultures  at  35-  37  weeks  of  gestation,  and  giving  intra  partum 
antibiotic prophylaxis to women with positive cultures.
2. The risk based approach, which recommends administering intra partum 
antibiotic  prophylaxis  to  women  with  risk  factors,  when they  go into 
labour.
In 2002 a further study on the above two methodologies indicated 
that, routine screening for the infection would prevent approximately 50% 
more newborn infections, than would a risk –based approach. 7 This study 
along with other data, led to the revised guidelines formulated by the CDC.
The CDC revised guidelines August 2002 recommends screening all 
pregnant women at 35-37 weeks of gestation, with the vaginal and rectal 
swab for group B streptococcal culture7.Swabbing both the vagina and 
rectum through the anal sphincter increases the yield substantially, compared 
with sampling the cervix  or sampling the vagina alone without swabbing the 
rectum8 .Because vaginal and rectal swabs are likely to yield diverse 
bacteria, one of the selective enriched broth is recommended to maximize 
the isolation of group B streptococci and avoid growth of other organisms7.
Method for culturing group B streptococci in pregnant women 
Center for Disease Control (CDC) guidelines7.
Without using a speculum, sweep a single swab over the skin from the 
vaginal introitus to the anus. Place the swab in a suitable transport medium 
such as Amies medium. The swab can remain in the medium for up to four 
days.
Inoculate in one of the following selective broth media
a) Todd – Hewitt  broth supplemented with nalidixic acid 15micro gm 
per ml and either colistin 10 micro gm per ml or gentamicin 8 micro 
gm per ml or Commercially available culture medium such as SBM or 
Lim broth.
b) Incubate the culture for 18-24 hours 
c) Subculture the broth culture to a sheep-blood agar plate and incubate 
for 18-24 hours 
d) Inspect and identify organisms suggestive of group B streptococci
e) For  definitive  identification  use  group  B  streptococcal  antigen 
detection methods 
f) For presumptive identification use the Christie, Atkins and Munch – 
Peterson (CAMP) test.
Guidelines for intrapartum antibiotic prophylaxis to prevent perinatal 
GBS disease under a universal prenatal screening strategy based on 
combined vaginal and rectal cultures collected at 35–37 weeks’ gestation 
from all pregnant women (CDC guidelines7):
Indications for Intrapartum prophylaxis: 7
1.  Previous infant with invasive GBS disease
2.  GBS bacteriuria during current pregnancy
3.  Positive GBS screening culture during current pregnancy (unless a 
planned  cesarean  delivery,  in  the  absence  of  labour  or  amniotic 
membrane rupture, is performed)
4. Unknown  GBS  status  (culture  not  done,  incomplete,  or  results 
unknown) and any of the following:
• Delivery at <37 weeks’ gestation
• Amniotic membrane rupture >18 hours
• Intrapartum temperature >100.4°F (>38.0°C)
Intrapartum prophylaxis not indicated in
1. Previous pregnancy with a positive GBS screening culture (unless a 
culture was also positive during the current pregnancy)
2. Planned  cesarean  delivery  performed  in  the  absence  of  labour,  or 
membrane    rupture (regardless of maternal GBS culture status)
3. When vaginal and rectal GBS screening culture are negative in late 
gestation during the current pregnancy, regardless of intrapartum risk 
factors.
Recommended regimen: 
Penicillin G, 5 million units IV initial dose, then 2.5 million units IV 
every 4 hours until delivery
Alternative   regimen:
Ampicillin, 2 g IV initial dose, then 1 g IV every 4 hours until 
delivery
If allergic to penicillin
1. Patients not at high risk for 
anaphylaxis
Cefazolin, 2 g IV initial dose, then 
1 g IV every 8 hours until delivery
2. Patients at high risk for 
anaphylaxis. a) GBS 
susceptible to clindamycin and 
erythromycin                 
Clindamycin, 900 mg IV every 8 
hours until delivery
OR
Erythromycin, 500 mg IV every 6 
hours until delivery
b) GBS resistant to 
clindamycin or erythromycin 
or susceptibility unknown
Vancomycin, 1 g IV every 12 
hours until delivery
Clinical challenges
Group B streptococci bacteruria during pregnancy
The presence of bacteruria in any concentration in pregnant women is 
a marker for heavy genital tract infection. Therefore any women with any 
quantity of group B bacteruria during pregnancy should receive intrapartum 
chemoprophylaxis. Vaginal and rectal screening at 37- 38 weeks is not 
necessary for these women. Women with such bacteruria or urinary tract 
infections with group B streptococci should receive appropriate treatment at 
the time of diagnosis as well as intrapartum prophylaxis.
Planned caesarean delivery
Because group B infection can cross the intact amniotic membranes, a 
caesarean delivery does not prevent mother to child transmission of the 
infection.
Threatened preterm delivery
Because preterm delivery is an important risk factor for early onset 
group B streptococcal disease, and because timing of delivery can be 
difficult to asses, management of intrapartum prophylaxis for women with 
threatened preterm delivery can be challenging.
Suggested Group B Streptococcal Prophylaxis for Women with 
Threatened Preterm Delivery  7 
Adverse Effects and Unintended Consequences of 
Chemoprophylaxis
Potential adverse or unintended effects of GBS prevention efforts that 
have raised concern include allergic or anaphylactic reactions to agents used 
for intrapartum antibiotic prophylaxis, emergence of GBS strains resistant to 
standard therapies, and increasing incidence of serious neonatal infections 
Stop penicillin
Onset of labor or rupture of membranes at <37 weeks gestation 
with significant risk for imminent preterm delivery
No GBS culture GBS+ve GBS-ve
Obtain vaginal and 
rectal GBS culture 
and initiate IV 
penicillin
Penicillin IV for 
48 hrs
(during tocolysis)
No GBS 
Prophylaxis 
Intrapartum 
Prophylaxis
GBS+ve
No growth at 48 hrs
caused by pathogens other than GBS, including antimicrobial-resistant 
strains. Because of the increasing emergence of bacterial resistance to 
antimicrobial agents in nosocomial and community settings, assessment of 
the impact and continued effectiveness of interventions based on 
antimicrobial prophylaxis is critical.
Future prevention technology
Rapid tests to detect group B streptococcal colonization
Rapid tests for detection of GBS colonization at the time of labour or 
rupture of amniotic membranes might obviate the need for prenatal culture 
based screening, provided their sensitivity and specificity are comparable to 
culture in selective broth media, and they yield results rapidly enough to 
permit administration of adequate intrapartum antibiotic prophylaxis, to 
women detected as carriers.
Currently available rapid tests, detect GBS antigen from swab 
specimens. These tests are insufficiently sensitive to detect light colonization 
and therefore are not adequate enough to replace culture based screening 
method.7
On going trials in other parts of the world involve a new fluorogenic 
polymerase chain reaction assay. This assay is found to be 97% sensitive 
and 100% specific when compared to the rectal and vaginal cultures. Further 
the test results from this assay are available within 45 minutes of specimen 
collection.8
Further studies are needed to determine whether this type of test can 
be adapted for use outside the research setting. If appropriate techniques for 
rapid detection of GBS become commercially available, they may be 
integrated into the currently recommended screening strategy.
Vaccines to prevent GBS disease
Serotype specific antibodies to GBS capsular polysaccharide, 
although rare in population of unvaccinated women, have been shown to 
protect against the disease9. These vaccines in the initial trails are found to 
be well tolerated and immunogenic.
The challenges faced with vaccination implementation are,
1. Large and appropriate sample size is necessary to demonstrate vaccine 
efficacy.
2. Duration of protection offered by the vaccine is currently unknown.
3. Shifts in the GBS serotypes responsible for infection over time10
Hence until a safe, effective, and economical vaccine achieves licensure, it is 
very much important to continue current recommendations of screening and 
treatment.
REVIEW OF LITERATURE
Puerperal sepsis has been described for centuries and ancient 
Indian texts in 1500 B.C have recorded that good hygiene leads to a 
reduction in the perinatal disease.11
In 1879 Louis Pasteur identified streptococcus as a causative 
organism for puerperal sepsis. 12
Since the early 1930’s when Rebecca Lancefield reported her 
grouping system for hemolytic streptococci, group A streptococcus 
(streptococcus pyogenes) was wildly acknowledged as the major pathogen 
associated with puerperal sepsis.13
Group B streptococcus was initially thought to be a commensal, 
until 1937 when Fry reported several cases of group B streptococcus 
associated puerperal fever with three deaths. 14
During the 1970’s and 1980’s, group B streptococci emerged as 
a significant neonatal and maternal pathogen in the United States and 
Western Europe with reported mortality rates of 15 to 50 percent. 15
In the early 1980’s clinical trials demonstrated that 
administering antibiotics during labour to women at risk of transmitting the 
group B streptococcal infections to newborns could prevent invasive disease 
in the first week of life. 16.
In 1981 in a prospective study of colonization with group B 
streptococci among 6706 parturients, Regan JA, Chau.S, James LS found an 
increased incidence of premature rupture of membranes and preterm 
delivery in patients colonized with GBS. Premature rupture of membranes 
occurred in 8.1% of the non-colonized population and 15.3% of the 
colonized population. Preterm delivery occurred in 1.8% of the non 
colonized population and among 5.4% of the colonized women.17
McDonald, Vigneshwaran .R, O’Loughlin JA, did a prospective 
study with vaginal swabs obtained from 692 women at 35-36 weeks of 
gestation. GBS was detected in 91(13.2% of the women). The rate of 
preterm labour, less than 37 weeks was significantly higher in GBS positive 
women than in GBS negative women (18.7% Vs 5.5%). This association 
remained significant even when patients with other recognized factors 
predisposing to preterm labour were excluded (11.5% Vs 3.9%). 
The rate of premature rupture of membranes was also 
significantly higher in the GBS positive women (9.9% Vs 2.7%) and 
remained higher when patients with other recognized risk factors were 
excluded (6.1% Vs 1.8%). The results unequivocally showed that the 
pregnant women who were vaginal carriers of GBS have a significantly 
increased risk of premature rupture of membranes and preterm labour .18
Regan JA, Klebanoff MA, Nugent RP et al studied the 
association of cervico vaginal colonization of group B streptococci with 
pregnancy and neonatal outcome. Genital tract cultures were taken at 35 to 
37 weeks. The colonization rates were found to be 21%. There was 1.5 times 
increased risk of delivering a preterm (14.7%) and low birth weight infant 
(20.6%) in GBS positive women when compared to GBS negative women. 
Neonatal sepsis occurred in 2.6 per 1000 live births in women with GBS 
colonization and 0.4 per thousand live births in women without GBS 
colonization.19
In a study involving 326 antenatal women, Chau.S, Arul 
kumaran .S observed the group B streptococci colonization in 14.1% of 
pregnant women. All the patients were screened after 32 weeks of gestation. 
They further concluded that, antenatal screening for GBS carrier status prior 
to 32 weeks of gestation might not identify women at high risk of preterm 
labour or premature rupture of membranes.20
Liang ST, Lau SP, Fok TF reported carriage of GBS after 34 
weeks of gestation to be 19%. Incidence of GBS infection in neonates was 
found to be 1.6 per thousand livebirths.21
CHS Chan, KM wan, WH Lee, in a prospective study involving 
986 antenatal women found that the maternal carriage rate of GBS was 24%. 
The incidence of premature rupture of membranes in GBS positive patients 
was found to be 14.2% and the incidence of preterm labour was found to be 
20%. These rates were significantly higher when compared to women who 
were not colonized with GBS .22
The incidence of GBS related sepsis was found to be 1.3 per 
1000 live births. The rate of neonatal admission in the GBS positive group 
was 67%, which was significantly higher when compared, to the women 
with GBS negative status.22  
Manuel et al in a study involving antenatal Spanish women 
found that the maternal carriage rate of GBS to be 14.6%. The incidence of 
preterm labour was 35% in the GBS positive women and 7% in GBS 
negative women .The association of GBS positive status with preterm labour 
was significant.23
Lucto M, Sanches MJ et al did a universal ante partum vaginal 
culture of all the antenatal patients after 34 weeks of gestations and found 
that the rate of maternal GBS colonization to be 12%.24
Tim SF, Lyon BJ, Chung KH reported that the genital carriage 
of GBS is 7.4% in Chinese population .25
   Zalenik .DF et al did a prospective study in 695 antenatal 
women and stated that the rate of group B streptococcal colonization in 
Asian women to be 14% .26
McDuffe RS Jr, Mc Nabb.F, Fryer GE et al did a prospective 
study in antenatal women at 32 weeks of gestation. 18% of the patients were 
found to be colonized with GBS and there was an increased incidence of 
preterm labour (13%), premature rupture of membrane (13%), prolonged 
labour more than 12 hours (33%), and chorio amnionitis (9%) when 
compared to GBS negative patients .27
Boyer KM studied the perinatal effects of GBS colonization. 
The incidence of GBS sepsis was found to be 1.8 per 1000 live births and 
the case fatality ratio due to group B streptococcus was found to be 10 to 
20%.28
Mariijane A, Krohn et al studied the maternal peripartum 
complications associated with vaginal group B streptococcal colonization. 
The incidence of intra amniotic infection in colonized women was found to 
be 2.2%. The incidence of post partum endometritis was seen in 2% of the 
patients. The percentage of patients in the study group colonized with GBS 
was found to be 21.6%.29
Katz VL et al studied the maternal colonization of GBS and 
found to be varying from 15 to 30% among various racial groups. Further 
the rate of invasive infection in newborn was found to be 1-3% per 1000 live 
births.30
Kosheleva et al studied the effect of maternal colonization on 
pregnancy outcome and reported the incidence of preterm labour in GBS 
positive women as 21.7% and the incidence of PROM as 13.7%. Further the 
perinatal mortality of babies born to GBS positive mothers was found to be 
12.6%.31
Gerards CJ, Hoog, Korslange JA et al studied the influence of 
group B streptococcal carrier state, on pregnancy outcome and found that the 
race and age group have no specific implication with regard to GBS 
colonization .The percentage of low birth weight babies (<2.5kg) was found 
to be 30% and these rates were significantly higher when compared to that 
of women in the negative group. The transmission frequency of GBS 
infection to neonates was found to be 46%.32 
Campel et al did a cross sectional study in antenatal women and 
found a GBS carrier rate of 22%. The rate of neonatal sepsis was found to be 
1.4 per 1000 live births .The neonatal mortality in GBS positive group was 
found to be 10.6% .33
Matorras R, Garcia Percea A et al studied the effect of maternal 
colonization by group B streptococci in 1050 pregnant women. They found 
that there is an increased incidence of premature rupture of membranes 
(26.4%) in patients colonized with GBS as against non-colonized (7.8%). 
The prevalence of low birth weight babies less that 2.5 Kg (25.4%) was 
found to be significant in patients with GBS, when compared to non-
colonized patients .34
Garland SM, Kelly N, Ugoni AM concluded in a study at Royal 
Women’s hospital that the prevalence of group B streptococci among 
pregnant women was 12.9%.35 
Badri MS et al did a cross sectional study to detect the rate of 
maternal colonization and found to be 20.5%.36 
Feikin DR, Thorsen P, Zvwickis conducted a study to assess the 
association between colonization with group B Streptococci during 
pregnancy and preterm delivery in Danish women. They found that, more 
women with preterm delivery (12/84 = 14%) were colonized with group B 
Streptococci, than women with term deliveries (22/300 = 7%). Group B 
Streptococcal colonization at less than 24 weeks, was not significantly 
associated with preterm delivery.37
Regan and associates while analyzing data from Vaginal 
Infections and Prematurity (VIP) study, suggested that the colonization with 
group B Streptococci is associated with preterm, premature rupture of 
membranes, neonatal death from sepsis and risk of postpartum endometritis, 
suggesting that both pregnancy and neonatal outcomes are affected with the 
infection.38
Hastings MJ, Easmon CS, Neill J observed that vaginal 
colonization of pregnancy was not related to age, parity or blood group. 
They also stated that vaginal group B Streptococcal colonization was 
significantly associated with intrapartum pyrexia and prolonged labour 
(20%) when compared to negative women. 39
Joshi AK, Chen CI, Turnell RW stated that higher rates of 
preterm delivery (15.6%) and of low birth weight (26.4%) was noted among 
the babies of colonized women than among the babies of all women 
admitted for labour and delivery. 40
Towers Craig V, Lewis David F observed that prevalence of 
Group B Streptococci in pregnant women is 13% when admitted for 
delivery. 41
Dalal S, Lahiri A, Parel CC in a study regarding the carriage 
rate of group B Streptococci, involving 507 pregnant Indian women, 
reported that 12% of the women had group B Streptococci isolated from the 
throat and vagina, 10% had positive cultures from the vaginal sample 
alone.42
Chaudhary U, Sabherwal U stated the carrier rate among 
pregnant women in India to be 16%.43
Mani V Jadhav M estimated the incidence of neonatal group B 
Streptococcal infection in India by calculating from the Indian 
epidemiological data. They reported the maternal and infant Group B 
Streptococcal colonization rates to be 14% and 50% respectively.44
AIM OF THE STUDY
1. To  study  the  prevalence  of  group  B  Streptococcal  infection  at  35-37 
weeks  of  gestation,  in  normal  asymptomatic  primi  gravida,  attending 
antenatal clinic in a level three tertiary care institution.
2. To  evaluate  and  compare  the  incidence  of  preterm labour,  premature 
rupture of membranes and puerperal morbidity in group B streptococcal 
colonized and non-colonized women.
3. To  study  and  compare,  the  effect  of  colonization  on  the  mode  of 
termination  of  the  pregnancy,  in  group  B  streptococci  positive  and 
negative women.
4. To  evaluate  the  fetal  outcome  and  morbidity  in  colonized  and  non 
colonized mothers  in the form of Neonatal  Intensive care Unit(NICU) 
admissions, duration of stay and incidence of neonatal mortality.
SUBJECTS AND METHODS
All primi gravid women of 35-37 weeks of gestation attending the 
antenatal clinic of Institute of social obstetrics and Government Kasturba 
Gandhi Hospital for women and children, Triplicane, Chennai were recruited 
for the study, based on the inclusion and exclusion criteria.
The study was approved by the hospital ethical committee.
Methodology
Study Design : Analytical Study
Place of study : Institute of social obstetrics and Government 
Kasturba Gandhi Hospital for Women and 
Children, Chennai – 600005
Duration of Study: January 2006 to July 2007.
Inclusion Criteria :
1. Primi with singleton gestation at 35-37 weeks of gestation
2. Cephalic presentation
3. No history of sepsis or any other infection in the antenatal period
4. No other medical or surgical complications
5. Not on any long term therapy
Exclusion Criteria:
1. All multigravida
2. Primi gravida with less than 35 weeks of gestation
3. Non cephalic presentation
4. Multiple pregnancy
5. All high risk pregnancies
6. Patients with uterine anomalies
7. Associated medical and surgical illness complicating pregnancy
8. Past history of sepsis in the antenatal period
9. Patients on any long term therapy.
Sample size: - 300 women based on the inclusion and exclusion criteria
A detailed history was taken in all the women recruited for the study. The 
following basic investigations were done in all women.
• Height 
• Weight
• Body mass index
• Blood pressure, pulse rate
• Cardiovascular and respiratory examination
• Obstetric examination
• Urine albumin and sugar
• Complete hemogram
• Blood sugar, urea
• HbsAg
• HIV after getting consent
• Swab for GBS
• Smear for TV, Moniliasis
• Ultrasound  examination  for  gestational  age,  anomalies,  cervical 
length, internal os diameter.
Method of Swab Collection: (according to CDC guidelines 
August 2002)
1. Without using a speculum a single sweep of the sterile swab over the skin 
from the vaginal introitus to the anus was taken.
2. The swab was immediately placed in Amies transport medium.
3. Then the swab was inoculated in Todd – Hewitt broth supplemented with 
nalidixic acid 15microgram/ml and gentamicin 8microgram/ml.
4. The culture was incubated  at 37oC in 5-10% carbon dioxide for 18 to 24 
hrs 
5. Then the broth was sub cultured on tryptone soya agar enriched with 5% 
defibrinated sheep’s blood at 370C in 5-10% carbon dioxide for 18 to 24 
hrs.
6. Group B Streptococci was identified using CAMP (Christie, Atkins and 
Munch – Petersen) test
Composition of culture media
Amies transport media:
Charcoal, sodium chloride, phosphate buffer, potassium chloride, 
sodium thioglycollate, calcium chloride, magnesium chloride, agar.
Todd-Hewitt broth:
Meat infusion, tryptone, glucose, sodium bicarbonate, sodium 
chloride, di sodium phosphate.
According to the group B Streptococcus swab status whether positive 
or negative, the patients were followed up for the rest of the antenatal period 
and observed for the following parameters. 
Preterm labour - onset of labour prior to 37 completed weeks of gestation 
was taken as positive criteria for preterm labour.
Premature rupture of membranes – the rupture of membranes prior to the 
onset of labour is taken as the criteria.
All the deliveries were monitored with partogram.
Mode of Onset of Labor whether Spontaneous or Induced were recorded.
Mode of Delivery:
The patients were followed up and the type of delivery noted.
Prolonged Labour:
Labour was considered prolonged when it grossly exceeded the 
average duration of labour for the first and second stage, based on the 
partograph (6hrs for first stage and two hrs for second stage).
Neonatal Follow up:
1. One minute and five minute APGAR of all the babies were recorded.
2. Birth weight.
3. Neonatal admissions 
4. Duration of stay in Neonatal Intensive care unit (NICU).
5. Neonatal mortality.
Maternal Morbidity:
Maternal morbidity was assessed in terms of number of days of 
extended stay in the hospital. In our hospital the routine number of hospital 
days for patients delivered by labour natural is 3 days, by instrumental 
vaginal deliveries is 5 days and by LSCS is 7 days. Any patient requiring 
more than the above mentioned number of days according to the mode of 
delivery is taken, as an indirect criteria for accessing maternal morbidity.
Statistical Methodology:
All the assessed parameters were studied for all the 300 women and 
the data was analyzed using chi square test. The significant parameters were 
further studied using univariate analysis and the odds ratio and the 
confidence limits were arrived. A “p” value of < 0.05 was taken as 
statistically significant.
OBSERVATIONS
The total no of subjects screened were 300 out of which 47 patients 
were found to be positive for group B streptococcus and 253 patients were 
found to be negative for the culture.
Table 1: GBS prevalence
GBS POSITIVE GBS NEGATIVE TOTAL
47(15.66%) 253(84.33%) 300
The prevalence rate of Group B streptococci in asymptomatic primi gravida 
was found to be 15.66%
Table 2: Age in years
Age (in years) GBS +ve GBS -ve χ2valu
e
p-
valueN=4
7
% N=25
3
%
<21 7 14.8
9
27 10.6
7
0.90 0.64
21 - 26 37 78.7
2
204 80.6
3
> 27 3 6.38 22 8.69
There was no correlation between age of the women and presence or 
absence of GBS infection.
Table 3: Socio Economic Status
Socio-
economic 
status
GBS +ve GBS -ve χ2value p-value
N=47 % N=253 0.41 0.81
III 3 6.38 19 7.51
IV 28 59.57 138 54.54
V 16 34.04 96 37.94
Our hospital essentially caters to the women from the low socio 
economic group, population below the poverty line. 
The incidence of group B streptococci was found to almost 
equal in each of the socio economic class when compared between the GBS 
positive and negative group. 
However with the available data, the colonization does not 
seem to affect any particular socio economic class group.
                         Table 4: Preterm labour     
GBS N Preterm Labour χ2value p-value O.R. 
(95% 
C.I.)
Yes No
n % n % 9.6 0.002 4.1 
(1.4 , 
11.7)
Positive 47 8 17.0
2
39 82.9
7
Negative 253 12 4.74 241 95.2
5
It was observed that 8(17.02%) patients who were colonized with the 
organism went in for preterm labour whereas 12 (4.74%) patients who were 
not colonized developed preterm labour.
 
The association between preterm labour and GBS positivity was 
found to be statistically significant – p value of 0.002 (O.R-4.1(1.4, 11.7))
Table 5: Premature rupture of membranes
GBS N Premature rupture of 
membranes
χ2value p-value O.R. (95% 
C.I.)
Yes No
n % n % 6.4 0.01 4.1 (1.1 , 
15.2)Positive 47 5 10.63 42 89.36
Negative 253 7 2.76 246 97.23
The number of patients who developed premature rupture of 
membranes, was found to be 5(10.63%) and 7(2.76%) in group B 
streptococcal positive and negative women respectively. 
The association of premature rupture of membranes with 
streptococcus colonization was found to be statistically significant, with the 
positive patients having 4.1 times increased chances of developing 
premature rupture of membranes.
Table 6: Mode of onset of labour
GBS N Mode of onset of labour χ2value p-value
Spontaneous Elective 
Induction
Elective  
LSCS
n % n % n % 6.0 0.05
Positive 47 36 76.59 7 14.89 4 8.51
Negative 253 186 73.52 61 24.11 6 2.37
The mode of onset of labour in both group B streptococcal positive and 
negative women was compared.
• 36  patients  (76.59%)  in  the  positive  group  and  186  (73.52%)  in  the 
negative group went in for spontaneous labour
• 4 (8.51%) patients in the positive group and 6(2.37%) in the negative 
group underwent elective LSCS for non obstetric indications.
• 7 (14.89%) in the positive group and 61 (24.11%) in the negative group 
were  induced  electively.  The  percentage  of  patients  who went  in  for 
spontaneous labour was slightly more in the positive group than in the 
negative group. However this association was statistically insignificant.
Table 7: Increased duration of labour
GBS N PROLONGED 
LABOUR 
χ2-
Value
p-
VALUE
O.R. (95% 
C.I.)
Yes No
n % n % 38.5 0.00 11.5 (4.3 , 
31.6)Positive 47 14 29.7
8
33 70.21
Negative 253 9 3.55 244 96.44
The percentage of patients who went in for prolonged labour was 
29.78% (14/47) in the positive group and 3.55% (9/253) in the negative 
group. 
The association of increased duration of labour with group B 
streptococcal colonization was found to be statistically significant with p 
value of 0.00 (O.R11.5 (4.3, 31.6))
Table 8: Mode of Delivery
Mode of 
Delivery
GBS +ve GBS -ve χ2  
Value
p-
Value
O.R. (95% 
C.I.)N=47 % N=253 %
Vaginal 22 46.81 179 70.75 10.4 0.006 1.0 
(Reference)
LSCS 24 51.06 70 27.66 2.8 (1.5 , 5.3)
Instrumental 
vaginal 
deliveries
1 2.12 4 1.58 2.0 (0.2 , 
19.0)
The mode of delivery in all the three hundred patients was followed 
up.
The incidence of LSCS in GBS positive patients was found to be 
51.06% and that in the GBS negative group was found to be 27.66%.
 It was found that LSCS delivery is more common in group B 
streptococcal positive patients than in negative patients with p value of 0.006 
(O.R.2.8(1.5,5.3)
Table  9: APGAR score at one minute
GBS N APGAR score at 1 minute χ2- 
Value
p-value
>7 5 – 7 <5
n % n % n % 1.87 0.002
O.R2.3(1.1,
5.0)
Positive 47 33 70.2
1
5 10.6
3
9 19.1
4
Negative 25
3
21
4
84.5
8
2
7
10.6
7
1
2
4.74
The  APGAR score  of  all  the  babies  born  to  the  study  group was 
observed and it  was found that the babies born to Group B streptococcal 
colonized  mothers  were  having  low APGAR score  than  when  compared 
with that of the positive group.
 It  was  found  that  in  Group  B  streptococcus  positive  patients  14 
(29.7%)  of  the  infants  had  APGAR scores  less  than  7  and  in  Group  B 
negative patients there were 39 (15.4%) of them. The association of such 
low APGAR scores was found to be statistically significant.
Table 10: APGAR score at five minutes
GBS N APGAR score at 5 minutes χ2  
Value
p-value
>7 5 – 7 <5
n % n % n % 9.7 0.008 
O.R2.3 
(0.9,5.4)
Positive 47 37 78.7
2
7 14.8
9
3 6.3
8
Negative 25
3
23
5
92.8
8
14 5.53 4 1.5
8
In  the  same  way  as  one  minute  APGAR  score,  the  five  minutes 
APGAR score  was compared  in  both  Group B streptococci  positive  and 
negative patients. Scores of less than 5 was seen in 3 in the positive group 
and 4 in the negative group.
The APGAR score of less than 7 was seen in 10 (21.2%) of the Group 
B streptococcal positive patients and in 18(7.11%) of the negative patients. 
The association of low five minute APGAR scores with positive patients 
was found to be statistically significant. (p value 0.008).
Table 11: Birth weight
GBS N
Birth Weight
p-
value
<=2 
Kg.
2.1 – 2.5 
Kg.
2.6 – 3 Kg. >=3.1 
Kg.
0.003 
n % n % n % n %
Positive 47 3 6.3
8
24 51.06 16 34.04 4 8.51
Negative 253 4 1.5
4
76 30.03 152 60.07 21 8.30
                         χ2    Value-13.9      p value 0.003
O.R.-2.9 (1.5, 5.8)
The birth weight of the newborns born to the patients in the study 
group was divided in to above categories.
 
It was found that 51.06% of the babies born to the mothers in the 
positive group were having birth weight between 2.1 -2.5 kg, where as 
60.7% of the newborns in the negative group were having birth weights in 
the range of 2.6 -3 kg.
Table 12: Neonatal admission
GBS N Neonatal admission in 
NICU
χ2  
Value
p-value O.R. (95% 
C.I.)
Admitted Not 
admitted
n % n % 13.3 0.0003 4.6 (1.8 , 
12.1)Positive 47 10 21.27 37 78.72Negative 253 14 5.53 239 94.46
The number of babies admitted in the intensive care unit in the group 
B streptococcal positive group were 10(21.27%) and in negative group were 
14(5.53%). 
There was significant association between, positive patients and the 
need for neonatal admission.  
 Table 13: Indications for neonatal admission.
Reason  GBS positive
N=10 babies
GBS negative
N=14 babies
Fetal distress 4 5
Low birth weight 3 4
Other indications 3 5
All the low APGAR babies and very low birth weight babies in both 
the category were admitted.
Table 14: Number of NICU days for the baby
GBS N No. of NICU days for the baby χ2-
Value
p-value
<=5 6 - 9 >=10
n % n % n % 2.99 0.22
Positive 10 4 40 3 30 3 30
Negative 14 10 71.42 3 21.43 1 7.14
In the positive group 4 babies with fetal distress required admission 
for less than 5 days. 3 babies with low birth weight required admission for 
more than 10 days. The rest of the 3 babies, admitted for other reasons 
required NICU days ranging from 6-9 days.
In the negative group, three babies admitted for low birth weights 
required NICU stay between 6-9 days, one low birth weight baby was 
admitted for more than 10 days. The rest of the 10 babies in the negative 
group, admitted for fetal distress and for other reasons, required less than 5 
days of NICU stay.
The number of NICU days required were found to be more in the case 
of positive patients when compared to that of the negative patients. 
However this was statistically found to be insignificant.
 Out of the total number of babies under the study four (4/47) 
babies in the positive group developed signs and symptoms of neonatal 
sepsis, with two (2/253) babies in the negative group developed signs and 
symptoms of neonatal sepsis.
 The association of neonatal sepsis with GBS positivity was not 
significant when compared to GBS negativity (p-0.15). The rate of sepsis 
among GBS positive babies was found to be 8.51% (4/47), in negative group 
was found to be 0.79%(2/253)
TABLE 15: Neonatal mortality
GBS N Neonatal mortality χ2 -
Value
p-value
Yes No
n % n % 0.7 0.4
Positive 47 1 2.12 46 97.87
Negative 253 2 0.79 251 99.21
0ut of the 47 babies in the positive group one baby died of sepsis due 
to streptococcal bacteremia and there were two deaths in the negative group 
which were due to causes other than sepsis. There was no statistical 
significance between the GBS status of mother and neonatal mortality when 
compared among the two groups.
                          Table 16: Maternal morbidity
GBS N Extended hospital days χ2  
-Valu
e
p-
value
O.R. (95% 
C.I.)Yes No
n % n % 38.5 0.00 7.7 (3.6 , 
16.7)Positive 47 21 44.68 26 55.32
Negative 25
3
24 9.48 229 90.51
The maternal morbidity was measured in terms of extended number of 
hospital stay days required, excluding the compulsory days of admission due 
to neonatal admissions.
 It was found that 21(44.68%) of the positive patients stayed in the 
hospital for a longer period of time as against 24 (9.48%) patients in the 
negative group. 
It is found that there is a significant association between group B 
streptococcal positivity and maternal morbidity. (p value 0.00)
Table 17: Extended number of hospital days for the mother
GBS N Extended number of hospital days for 
the mother
χ2-
Value
p-
value
<=5 6 – 9 >=10
n % n % n % 2.7 0.25
Positive 21 8 38.0
9
12 57.1
4
1 4.76
Negative 24 15 62.5 8 33.3
3
1 4.16
When computed in terms of the actual number of days it was found 
that 61.9% of the patients in the positive group required more than 5 days for 
recovery whereas only 37.49% of the patients in the negative group required 
more than 5 days for recovery.
DISCUSSION
This study on the influence of GBS infection on the various aspects of 
pregnancy, labour , fetal outcome was conducted at the Institute of Social 
Obstetrics and Government Kasturba Gandhi Hospital For Women and 
Children between January 2006 and July 2007 , in 300 asymptomatic 
antenatal women attending the antenatal clinic . 
When the rate of GBS colonization (Table 1) among the pregnant 
women was analyzed it was found that the rate of colonization differ world 
wide between 12-24%. In India the rate of colonization varies between 14-
18%. 
Name of the study GBS prevalence rate 
Regan JA, Klebanoff et al 19 21%
McDonald, Vigneshwaran R, O’Loughlin18 13.20%
ChauS, Arul Kumaran et al20 14.10%
Liang ST, LauSP, Fok TF 21 19%
CHS Chan, KM Wan, WH Lee22 24%
Manuel et al 23 14.60%
Lucto M et al 24 12%
Tim SF, Lyon DT, Chung KH 25 7.40%
Zalenik DF et al 26 14%
McDuffe RS Jr, Mc Nabbs 27 18%
Mariijane, Krohn et al 29 21.60%
Katz et al 29 15-30%
Campdel et al 33 22%
Garland SM, Kelly N 35 12.90%
Badri MS et al 36 20.50%
Towers Creig V, Lewis David 41 13%
Dalal S Lahiri 42 10%
Mani V, Jadhav 44 14%
Choudary et al 43 16%
Present study 15.66%
The prevalence of group B streptococci in the present study is 
comparable to that of studies mentioned above. It is to be noted that, the 
prevalence of group B streptococci in most of the studies is around 14%, 
except in 3-4 studies where it is around 20%.Hence the global incidence can 
be taken as 14%.
In table 2, the prevalence of group B streptococci towards the age 
groups <21, 22-26,>27 years were analyzed. It was found that there was no 
correlation, between the presence of GBS infection and the age group.
Similarly in table 3, the prevalence of GBS positivity in a particular 
socio economic group was analyzed, though there were no patients in class 1 
and class 2 socio economic statuses included in the study, there was no 
significant correlation between the class 3, class 4 and class 5 socio 
economic patients and GBS colonization.
The same observation was observed in a few other studies also
Gerards CJ, Lab BP, Hoog 32 found no correlation between age and 
GBS colonization. Hastings MJ, Easmons CS, Neill J 39 could not ascertain 
any correlation between age, blood group and GBS colonization
The incidence of preterm labour in GBS positive women was 
analyzed as in table 4.
Name of the study Percentage of preterm 
labour in GBS +ve women
Regan JA, Chau S et al 17 18.00%
McDonald, Vigneshwaran, O’Loughlin18 18.70%
Regan JA, Klebanoff, Nugent 19 14.70%
CHS chan, KM Wan, WH Lee21 20.00%
Manuel et al 23 35.00%
McDuffee RS Jr, McNabbs27 13.00%
Koshelena et al 31  21.70%
Matorass R, Garecea Percea 34 28.20%
Feikin DR, Thorsen P et al 37 14.00%
Joshi, Chen et al 40 15.60%
Present study 17.02%
In all the above reference studies and the present study, the 
association of GBS positivity and preterm labour was found to be 
significant.
The prevalence of preterm labour in GBS positive patients in the 
present study was found to be 17.02% and in GBS negative patients it was 
found to be 4.74%. 
In this study the association of preterm labour, with GBS colonization 
was found to be statistically significant.
The incidence of preterm labour was found to be four times more 
common in patients colonized with GBS, than when compared to patients 
who were non-colonized.
The incidence of premature rupture of membranes (PROM) prior to 
the onset of labour was further analyzed as per table 5.
Name of the study Percentage of PROM 
in GBS +ve Patients
Regan JA, Chau S, James 17 8.10%
Mc Donald, Vigneshwaran, 
O’Loughlin18
9.90%
CHS Chan, KM Wan, WH Lee21 14.20%
McDuffee RS Jr, McNabbs 27 13.00%
Koshelena et al31 13.70%
Present study 10.63%
In all the above studies, including the present study the rate of 
premature rupture of membranes in GBS positive women was found to be 
significant, when compared to GBS negative women, when the results were 
statistically analyzed. In the present study it was further found, that PROM 
was four times more common in GBS positive women, when compared to 
GBS negative women.
After the above parameters the mode of onset of labour among the 
300 study population were analyzed (table 6)
Gerards CJ , Lab BP 35  studied the effect of streptococcus carrier state 
on the mode of onset of labour , and stated though a considerable percentage 
of patients with GBS colonization went in for spontaneous labour including 
preterm, premature rupture of membranes, there was no statistical 
correlation between the mode of onset of labour and GBS positive status.
The same was observed in our study (table 6) where 36(76.59%) GBS 
positive women went in for spontaneous labour and 186 (73.52%) GBS 
negative women went in for spontaneous labour .There was no specific 
statistically significant correlation, between GBS positive status and mode of 
onset of labour.
In table 7, the incidence of prolonged first & second stages of labour 
in GBS positive and GBS negative women were analyzed.
Name of the study Percentage of 
prolonged labour in 
GBS +ve Patients
McDuffee RS Jr, McNabbs 27 33%
Hastings MJ, Easmon CS, Neill J39 20%
Present study 32.55%
In all the above studies the incidence of prolonged labour, was found 
to be more common in patients who are colonized with GBS, than when 
compared to patients who were non-colonized.
The mode of delivery in study group was further analyzed as per table 
8. 
The rate of   operative deliveries were found to be more common in 
patients, who were streptococcus positive than compared to streptococcus 
negative patients. (51.06% in positive Vs 27.66% in negative women) This 
association between operative deliveries and GBS positive status was found 
to be statistically significant (p value 0.006).
Caesarean section in the GBS positive group were more commonly 
seen in those women who had increased duration of labour (8/14), and those 
who underwent elective induction (5/7).The rest of the caesarean (7/24) 
excluding the elective sections (4/24) were due do obstetric indications, 
developed during the process of labour.
Name of the study Percentage of operative 
deliveries
Katz et al 30 42.4%
Liang ST, Lab BP, Fok TF21 49.2%
Present study 51.06%
After delivery the APGAR scores of all the babies born to the women 
under study were analyzed .Gerards CJ, Lab BP, Hoog , Kamp Korstange JA 
32  in a study reported low APGAR score in GBS positive women when 
compared to GBS negative women (<5APGAR:10.2%)
The same was observed in our study with APGAR score at 1minute of 
less than 5 was seen in 9 babies (19.14%) of GBS positive women and 12 
babies (4.74%) in GBS negative women (table 9)
Similarly when 5 minute APGAR scores were tabulated it was found 
(table 10) that APGAR scores of less than five was seen in 3 babies, (6.38%) 
in GBS positive group  and in 4(1.58%) babies in the GBS negative groups.
Similar observations were reported by the following studies.
Name of the study <5 APGAR at 5 
minutes
CHS Chan, KM Wan, WH Lee 22 10%
Gerards CJ, Lab BP, Hoog,  Kamp 
Korstange JA 32
8.4%
Present study 6.38%
There was consistent correlation between low APGAR scores and 
GBS positive status, in the above reference studies and in the presence 
study.
Following APGAR scores, the birth weight of all the babies born to 
the women under the study group were analyzed. (Table 11).
Name of the study Percentage of low birth 
weight babies
Regan JA, Klebanoff, Nugent 19 20.6%
GerardsCJ, Hoog, et al 30.1%
Matorras, Garecea Percea et al 25.4%
Present study 57.44%
The increased incidence of low birth weight in our study may not be 
entirely attributed to GBS infection. Other factors such as genetic 
predisposition, antenatal nutritional status, maternal configurations, might 
have played a role in these babies being born as low birth weight infants. 
However, in all the studies mentioned above including the present study the 
incidence of low birth weight infants, was found to be statistically 
significant, when compared to that of GBS negative women.
Further the neonatal admission requirements and the number of NICU 
days required were analyzed as per tables 12, 13&14.
Name of the study Percentage of GBS infants 
admitted
Chan CHS, KM Wan, WH Lee 22 12%
Gerards CJ, Lab BP 32 19.5%
Bayer KM28 10-20%
Present study 21.27%
The varying rates of admission could be attributed to the various 
methods of standard operative protocols followed by each institution. The 
rate of neonatal admissions in GBS positive women (21.27%) was found to 
be statistically significant when compared to that of negative women 
(5.53%).
Our study had a higher rate of NICU admission. This could be due to 
the hospital policy of admitting babies with even mild distress. Moreover the 
three low birth weight babies in our study required extended duration of 
NICU stay.
The neonatal morbidity and mortality with group B streptococci were 
further analyzed. (Table 14&15)
Name of the study Neonatal sepsis
Regan JA, Klebanoff, 19 26%
Liang, Lan SP.Fok TF21 16%
CHS Chan, KM Wan, WH Lee22 13%
Boyer KM28 18%
Katz et al30 10-30%
Campbel et al33 14%
Present study 8.51%
The reason for the low incidence of sepsis can be attributed to the 
small sample size of the study. This could be also partially attributed to the 
improved tertiary, neonatal care available at our hospital. Further in our 
study when the rate of sepsis in infants born to GBS positive women 
(4/10admissions) and GBS negative women (2/14 admissions) were 
compared, the association between GBS positive status and sepsis rates were 
not significant. This may be due to the reason that this study was essentially 
a screening study and the patients under the study group were healthy 
asymptomatic individuals.
In the same way the fetal mortality due to sepsis and other reasons 
were analyzed (Table 15). There was one death among infants in GBS 
positive women due to sepsis, and two deaths in infants in the GBS negative 
group due to causes, other than sepsis. The association of GBS sepsis related 
mortality between GBS positive women and GBS negative women was not 
found to be statistically significant.
Name of the study Fetal mortality
Bayer KM et al21 10-20%
Koshelena et al 31 12.6%
Campbel et al 33 10.6%
Present study 2.12%
This low percentage of neonatal mortality may be due to   many 
factors such as small sample size, healthy mothers under study, improved 
neonatal care in the institution etc.
Following fetal parameters, maternal morbidity was analyzed by way 
of extended number of hospital days required before discharge of the 
mother, excluding the days arising out of compulsory stay due to neonatal 
admissions. The reasons were mostly due to sub involution of the uterus, 
post partum pyrexia, urinary tract infections, wound infections at the 
caesarean site and episiotomy wounds etc.
Name of the study Maternal morbidity
Mc Duffee RS Jr, Mc Nabbs 27 35.6%
Hastings et al 39 20%
Present study 44.68%
The high rate of maternal morbidity could be due to many reasons 
such as increased incidence of preterm labour, PROM, prolonged labour, 
increased incidence of operative deliveries etc. 
This increased rate could also be attributed to the prepregnant 
condition of the women, wherein most of them were undernourished because 
of their low socio economic status.
However maternal morbidity when compared between GBS positive 
and negative patients (44.68%vs 9.48%) was found to be significantly 
higher. Also the association of maternal morbidity with GBS positive status 
remained statistically significant.
There was no maternal mortality in the study group of both the 
categories.
SUMMARY
1. The prevalence of group B streptococcal colonization in asymptomatic 
primi  in the study population was 15.66%
2. The maternal colonization with group B streptococci was not related to 
age, and socio economic status of the patients.
3. There  was  an  increased  incidence  of  preterm  labour  (17.02%)  and 
premature  rupture  of  membranes  (10.63%) in  patients  colonized with 
group B streptococci, when compared to those who were not colonized.
4. There was an increased incidence of prolonged labour (29.78%), among 
the positive group when compared to the negative group (3.55%).
5. There was an increased incidence of low APGAR scores among babies 
born to positive women than when compared to negative women.
6. There was an increased incidence of operative deliveries among GBS 
colonized  women  (51.06%)  than  when  compared  to  GBS  negative 
women (27.66%).
7. There was statistically significant, increased rate of neonatal admissions 
(21.27%) and increased number of NICU days required by the babies 
born to GBS positive mothers than in the negative group.
8.  The incidence of sepsis in GBS positive mothers was 8.51%.However 
when analysed statistically the association between GBS positive status 
and the rate of sepsis in GBS positive mothers, was insignificant when 
compared to GBS negative mothers.
9. The mortality rate of the neonates in the GBS positive group was 2.3%. 
This low rate could be due to the improved neonatal care available at our 
institution.
10. There was significant maternal morbidity (analyzed in terms of extended 
number  of  hospital  days  required)  in  GBS  positive  group  (44.68%), 
when compared to GBS negative group.
11. There was no maternal mortality in both the groups.
From the above statements it could be inferred that the screening of all 
the pregnant women at 37-38 weeks of gestation, serves to be an important 
factor in reducing the incidence of preterm labour, premature rupture of 
membranes, and hence decrease the probability of low birth weight, low 
APGAR scores, and hence subsequent morbidity and mortality of both the 
mother and the newborn.
CONCLUSION
a. The prevalence of Group B streptococcus infection at 35-37 weeks of 
gestation in normal, asymptomatic primi attending the routine antenatal 
clinic in a level three tertiary care institution is 15.66%
b. The incidence of preterm labour in GBS colonized women is 17.02%, 
and in non colonized women is 4.74%. There is statistically significant 
increased risk of preterm labour in GBS positive women.
c. The incidence of premature rupture of membranes in colonized women is 
10.63%  and  in  non  colonized  women  is  2.76%.  The  association  of 
premature rupture of membranes and GBS positive status is statistically 
significant.
d. The  puerperal  morbidity  in  GBS  positive  women  is  44.68%,  and  in 
negative  women  is  9.48%.  There  is  significant  increased  puerperal 
morbidity in GBS positive women.
e. There is statistically increased incidence of operative deliveries (51.06%) 
in GBS positive women, when compared to negative women. (27.66%).
f. There  is  statistically  significant  increase  in  neonatal  morbidity  in  the 
form of increased neonatal admissions in GBS positive women (21.27%), 
when compared to GBS negative women. (5.53%).The number of days of 
NICU stay of the neonates was not significant in GBS positive women 
when compared to GBS negative women.
. 
g. The neonatal mortality rates were not significant (1/47 babies) in babies 
born to GBS positive patients when compared to GBS negative patients. 
(2/253 babies).
All the above conclusions, point out the importance of GBS screening 
during the antenatal period and the need to include it in the screening 
protocol of our health systems in the present era of evidence based medicine. 
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ANNEXURE
PROFORMA
Name 
Age
Socio economic status
Gestational age as per last menstrual 
period
Obstetric examination
Investigations 
Preterm labour yes/no
Premature rupture of membranes yes/no
Mode of onset of labour spontaneous/induced
Prolonged labour yes/no
Mode of delivery normal vaginal/IVD/  LSCS
APGAR score
one minute
five minutes
Birth weight
Neonatal admission yes/ no
Neonatal morbidity sepsis, pneumonia, severe 
respiratory distress, LBW/ 
others
Number of NICU days of admission
Neonatal mortality sepsis/others
Maternal morbidity yes/no
Extended number of hospital days
Maternal mortality yes/no
Key: CTG- cardio tocogram, IVD-instrumental vaginal deliveries LSCS-
lower segment caesarean section, NICU- neonatal intensive care unit, LBW-
low birth weight.


